Back
Cartesian Therapeutics Stock Predictions
Economic Policy Shifts = Huge Market Opportunity
See which of your stocks make the grade - analyze 3 stocks FREE.
Sell
37
RNAC
Cartesian Therapeutics
Last Price:
$11.07
Seasonality Move:
9.13%
7 Day Trial
ALL ACCESS PASS
$
7
Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.Cartesian Therapeutics Stock Forecast
-
Over the next 52 weeks, Cartesian Therapeutics has on average historically fallen by 8.1% based on the past 8 years of stock performance.
-
Cartesian Therapeutics has fallen lower in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Cartesian Therapeutics Stock Undervalued?The current Cartesian Therapeutics [RNAC] share price is $9.34. The Score for RNAC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
RNAC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Cartesian Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Cartesian Therapeutics has on average historically fallen by 8.1% based on the past 8 years of stock performance.
Cartesian Therapeutics Stock Rating
Sell
37
Cartesian Therapeutics (RNAC)
is a Sell
Is Cartesian Therapeutics overpriced?
-
Cartesian Therapeutics has fallen lower in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Cartesian Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cartesiantherapeutics.com
52-Week Data
52-Week High:
41.87
52-Week Low:
8.46
Prediction Charts
Market Cap:
242.4M
Price in USD:
9.34
Volume:
82.6K
Beta:
0.85
Technical Analysis
SMA50:
11.00
SMA100:
14.63
SMA200:
16.56
52-Wk Change:
-74.33%
Stock Predictions
-
Is Cartesian Therapeutics stock public?Yes, Cartesian Therapeutics is a publicly traded company.
-
What is the Cartesian Therapeutics stock quote today?The Cartesian Therapeutics stock price is 9.34 USD today.
-
How to buy Cartesian Therapeutics stock online?You can buy Cartesian Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-16 | 10.40 | 10.26 | 10.53 | 10.11 |
| May-19 | 10.26 | 10.37 | 10.41 | 9.91 |
| May-20 | 10.31 | 10.23 | 10.43 | 10.01 |
| May-21 | 10.10 | 9.28 | 10.10 | 9.25 |
| May-22 | 9.22 | 9.15 | 9.48 | 9.13 |
| May-23 | 9.01 | 9.16 | 9.36 | 9.00 |
| May-27 | 9.28 | 8.77 | 9.29 | 8.46 |
| May-28 | 8.79 | 9.09 | 9.37 | 8.76 |
| May-29 | 9.20 | 10.00 | 10.10 | 9.01 |
| May-30 | 10.00 | 9.56 | 10.02 | 9.36 |
| Jun-2 | 9.72 | 9.98 | 10.12 | 9.46 |
| Jun-3 | 9.98 | 9.90 | 10.12 | 9.80 |
| Jun-4 | 9.90 | 9.54 | 10.01 | 9.37 |
| Jun-5 | 9.55 | 9.34 | 9.55 | 9.01 |
Cartesian Therapeutics Earnings
Cartesian Therapeutics Earnings Report: Per Share Cartesian Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cartesian Therapeutics Forecast Revenue Growth
Cartesian Therapeutics Stock Analysis: Historical quarterly revenues per share for Cartesian Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and an increase next year of $1.95 per share.
* Cartesian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.